Jean-Simon Diallo

Jean-Simon Diallo is an Associate Professor in the Department of Biochemistry, Microbiology and Immunology at the University of Ottawa's Faculty of Medicine, and a Senior Scientist at the Ottawa Hospital Research Institute (OHRI) within the Centre for Cancer Therapeutics. His research bridges virology, pharmacology, and cancer immunotherapy.

• Education: B.Sc. (Biochemistry, University of Ottawa, 2000)
• M.Sc. (Biochemistry, McGill University, 2003)
• Ph.D. (Molecular Biology, Université de Montréal, 2007)

Research focuses on "viral sensitizer" drugs that enhance viral replication and therapeutic efficacy, with applications spanning:

• Oncolytic virotherapy for cancer
• Vaccine biomanufacturing
• Gene therapy delivery systems
• Antiviral drug discovery (e.g., SARS-CoV-2)

His methodology integrates:

• High-throughput molecular biology
• Medicinal chemistry
• Mass spectrometry analysis
• Translational research frameworks

Key collaborations include the multidisciplinary Diallo Lab at OHRI, where his team investigates small-molecule-virus interactions to expand therapeutic applications in oncology and infectious disease management.